Dexmedetomidine versus propofol or midazolam in patients with abdominal sepsis regarding inflammatory response and capillary leak
Moeen, S., Abdelhakeem, E., Abdalla, E., Embaby, I., Hassan, H., Ismail, E. (2022). Dexmedetomidine versus propofol or midazolam in patients with abdominal sepsis regarding inflammatory response and capillary leak. EKB Journal Management System, 38(1), 23-32. doi: TEJA-2021-0147
Seham M. Moeen; Essam E. Abdelhakeem; Esam M. Abdalla; Ibraheem Embaby; Hebatallah M. Hassan; Eman A. Ismail. "Dexmedetomidine versus propofol or midazolam in patients with abdominal sepsis regarding inflammatory response and capillary leak". EKB Journal Management System, 38, 1, 2022, 23-32. doi: TEJA-2021-0147
Moeen, S., Abdelhakeem, E., Abdalla, E., Embaby, I., Hassan, H., Ismail, E. (2022). 'Dexmedetomidine versus propofol or midazolam in patients with abdominal sepsis regarding inflammatory response and capillary leak', EKB Journal Management System, 38(1), pp. 23-32. doi: TEJA-2021-0147
Moeen, S., Abdelhakeem, E., Abdalla, E., Embaby, I., Hassan, H., Ismail, E. Dexmedetomidine versus propofol or midazolam in patients with abdominal sepsis regarding inflammatory response and capillary leak. EKB Journal Management System, 2022; 38(1): 23-32. doi: TEJA-2021-0147